Medication info
Euglex Tablet 2 mg (Glymepiride)

Euglex Tablet 2 mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Daewong Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP) × 3
Approval status
Active

MFDS item code 200300409 · Notified 2003.03.26 · Insurance code 641602100

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be considered. 4) Dosage adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after initial successful management, even when a sulfonylurea drug has been administered. Therefore, patients should be monitored closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea drugs such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug and metformin are used in combination, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Daewong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This drug is used to help control blood sugar in patients with type 2 diabetes along with diet and exercise. It can be used alone or in conjunction with oral hypoglycemic agents or insulin if blood sugar control is insufficient. In particular, this drug is added to improve blood sugar management when there is insufficient effect from sulfonylureas or monotherapy with metformin. This effectively enhances blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be considered. 4) Dosage adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after initial successful management, even when a sulfonylurea drug has been administered. Therefore, patients should be monitored closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea drugs such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug and metformin are used in combination, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those experiencing diabetic ketoacidosis or coma. Additionally, patients who have had allergic reactions to this drug or its components should not be administered this medication. The safety and efficacy of this drug have not been established in patients with very poor liver or kidney function, and insulin treatment is recommended in such cases. Women who are pregnant or likely to become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, those undergoing surgery, or those with significant trauma may require insulin treatment, so caution should be exercised before using this drug. Patients with gastrointestinal disorders such as diarrhea or vomiting may have inadequate drug absorption, increasing the risk of hypoglycemia. This drug contains lactose; therefore, patients with lactose intolerance or genetic lactose metabolism disorders should avoid using it. During the first week of taking this medication, close monitoring of blood glucose levels is essential due to an increased risk of hypoglycemia, particularly in elderly patients, those with irregular eating patterns, those in poor nutritional condition, heavy alcohol consumers, and individuals with compromised kidney or liver function. Also, caution is necessary in patients with other endocrine disorders or those who have overdosed on medications. If hypoglycemic symptoms occur while taking this drug, the patient should promptly inform a doctor or pharmacist, as dosage adjustments may be necessary. This medication can lower blood sugar, so hypoglycemia may occur. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, dizziness, drowsiness, and altered consciousness; in severe cases, it may lead to coma, necessitating immediate treatment. Additionally, initial use may result in blurred vision, gastrointestinal disturbances, liver function abnormalities, blood disorders, and allergic reactions, so any unusual symptoms should be reported to medical personnel immediately. This medication should be taken regularly to control blood sugar, and it is important to adhere to dietary and exercise regimens. If hypoglycemia occurs, consuming food containing sugar can quickly alleviate symptoms, so it is advisable to always carry a source of sugar. Regular blood sugar and urine tests should be conducted while on this medication, and dose adjustments may be necessary based on the patient's condition, as directed by a physician. This medication may interact with other drugs, so patients must inform healthcare providers of any other medications they are taking. In particular, some antibiotics, antifungals, antihypertensives, steroids, and alcohol may affect blood sugar control when taken concomitantly. In case of overdose, severe hypoglycemia may occur, so immediate emergency treatment is required, and intravenous glucose administration may be necessary at a hospital. The safety of this medication has not been confirmed in children, and particular caution is required in elderly patients who may have reduced kidney function when selecting a dose. Finally, this medication should be stored out of the reach of children, and it is safest to keep it in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, language impairment, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, anemia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial swelling, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP) × 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.